Abstract

Mapping protein–protein interactions is an invaluable tool for understanding protein function. Here, we report the first large-scale study of protein–protein interactions in human cells using a mass spectrometry-based approach. The study maps protein interactions for 338 bait proteins that were selected based on known or suspected disease and functional associations. Large-scale immunoprecipitation of Flag-tagged versions of these proteins followed by LC-ESI-MS/MS analysis resulted in the identification of 24 540 potential protein interactions. False positives and redundant hits were filtered out using empirical criteria and a calculated interaction confidence score, producing a data set of 6463 interactions between 2235 distinct proteins. This data set was further cross-validated using previously published and predicted human protein interactions. In-depth mining of the data set shows that it represents a valuable source of novel protein–protein interactions with relevance to human diseases. In addition, via our preliminary analysis, we report many novel protein interactions and pathway associations.

Details

Title
Large-scale mapping of human protein–protein interactions by mass spectrometry
Author
Ewing, Rob M 1 ; Chu, Peter 2 ; Elisma, Fred 3 ; Li, Hongyan 2 ; Taylor, Paul 2 ; Climie, Shane 2 ; McBroom-Cerajewski, Linda 2 ; Robinson, Mark D 2 ; O'Connor, Liam 2 ; Li, Michael 2 ; Taylor, Rod 2 ; Dharsee, Moyez 1 ; Ho, Yuen 2 ; Heilbut, Adrian 2 ; Moore, Lynda 2 ; Zhang, Shudong 2 ; Ornatsky, Olga 2 ; Bukhman, Yury V 2 ; Ethier, Martin 3 ; Sheng, Yinglun 3 ; Vasilescu, Julian 3 ; Abu-Farha, Mohamed 3 ; Lambert, Jean-Philippe 3 ; Duewel, Henry S 2 ; Stewart, Ian I 1 ; Kuehl, Bonnie 2 ; Hogue, Kelly 2 ; Colwill, Karen 2 ; Gladwish, Katharine 2 ; Muskat, Brenda 2 ; Kinach, Robert 2 ; Sally-Lin Adams 2 ; Moran, Michael F 2 ; Morin, Gregg B 2 ; Topaloglou, Thodoros 4 ; Figeys, Daniel 5 

 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Infochromics, MaRS Discovery District, Toronto, Ontario, Canada 
 Protana (now Transition Therapeutics), Toronto, Ontario, Canada 
 Faculty of Medicine, The Ottawa Institute of Systems Biology, University of Ottawa, BMI, Ottawa, Ontario, Canada 
 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Information Engineering Center, Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada 
 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Faculty of Medicine, The Ottawa Institute of Systems Biology, University of Ottawa, BMI, Ottawa, Ontario, Canada 
Section
Article
Publication year
2007
Publication date
2007
Publisher
EMBO Press
e-ISSN
17444292
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2299176012
Copyright
© 2007. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.